Adial Pharmaceuticals Inc ADIL
$4.15
▲ +2.72%
(+$0.11)
🎈 Low Float
Open
$4.04
Prev Close
$4.04
Day Range
$3.97 – $4.30
52W Range
$1.31 – $249.81
Market Cap
$10.90M
Beta
-379.86
EPS (TTM)
$-16.57
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-07-27 |
| Shares Out. | 2,580,000 |
| Website | adialpharma.com/ ↗ |
| Phone | 14344229800 |
| Employees | 6 |
| Revenue | $0 |
| Gross Profit | $0 |
| Net Income | -$52.0M |
| Free Cash Flow | -$11.1M |
| Total Assets | $29.1M |
| Total Liabilities | $28.9M |
| Equity | -$38.4M |
About Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Adial Pharmaceuticals Inc is a publicly traded company under the ticker symbol ADIL on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-09-01)